Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Chemicals Industry Analysis

UpdatedMar 02, 2026
DataAggregated Company Financials
Companies129
  • 7D1.0%
  • 3M17.9%
  • 1Y3.7%
  • YTD16.5%

The Chemicals industry is up 1.0% in the last week, with Linde up 2.2%. This takes the industry's 12 month performance to a gain of 3.7%. Earnings are forecast to grow by 21% annually.

Industry Valuation and Performance

Has the U.S. Chemicals Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 04 Mar 2026US$845.3bUS$356.9bUS$7.3b24x116.2x2.4x
Fri, 30 Jan 2026US$787.1bUS$371.5bUS$9.8b25.7x80.1x2.1x
Sun, 28 Dec 2025US$727.2bUS$371.7bUS$11.0b23.9x66.1x2x
Tue, 25 Nov 2025US$707.9bUS$371.7bUS$11.0b22.2x64.4x1.9x
Thu, 23 Oct 2025US$751.1bUS$367.8bUS$15.6b25.4x48.3x2x
Sat, 20 Sep 2025US$781.8bUS$367.7bUS$15.5b26.8x50.3x2.1x
Mon, 18 Aug 2025US$788.5bUS$367.8bUS$15.7b25.1x50.3x2.1x
Wed, 16 Jul 2025US$795.4bUS$376.6bUS$17.9b22.7x44.3x2.1x
Fri, 13 Jun 2025US$788.0bUS$378.4bUS$18.1b22.4x43.4x2.1x
Sun, 11 May 2025US$754.7bUS$378.5bUS$17.2b21.5x43.9x2x
Tue, 08 Apr 2025US$711.9bUS$380.9bUS$23.0b17.5x31x1.9x
Thu, 06 Mar 2025US$796.9bUS$380.3bUS$22.9b22.7x34.8x2.1x
Sat, 01 Feb 2025US$832.5bUS$382.1bUS$23.3b23.5x35.8x2.2x
Mon, 30 Dec 2024US$787.8bUS$384.3bUS$23.4b20.4x33.6x2x
Wed, 27 Nov 2024US$872.8bUS$384.3bUS$23.5b22.9x37.2x2.3x
Fri, 25 Oct 2024US$887.0bUS$388.9bUS$24.2b25.9x36.7x2.3x
Sun, 22 Sep 2024US$866.7bUS$383.8bUS$23.4b25.3x37x2.3x
Tue, 20 Aug 2024US$840.5bUS$384.5bUS$23.8b25.5x35.3x2.2x
Thu, 18 Jul 2024US$837.8bUS$379.9bUS$23.4b28.1x35.8x2.2x
Sat, 15 Jun 2024US$819.6bUS$377.3bUS$23.4b25.9x35x2.2x
Mon, 13 May 2024US$831.5bUS$377.4bUS$23.5b22.7x35.4x2.2x
Wed, 10 Apr 2024US$842.5bUS$384.6bUS$25.6b22.3x32.9x2.2x
Fri, 08 Mar 2024US$835.8bUS$384.5bUS$25.4b21.3x33x2.2x
Sun, 04 Feb 2024US$788.7bUS$397.0bUS$31.0b21.1x25.5x2x
Tue, 02 Jan 2024US$810.5bUS$397.9bUS$31.5b21.7x25.7x2x
Thu, 30 Nov 2023US$763.5bUS$398.8bUS$31.6b19x24.1x1.9x
Sat, 28 Oct 2023US$709.5bUS$404.8bUS$30.7b15.2x23.1x1.8x
Mon, 25 Sep 2023US$749.3bUS$412.0bUS$31.2b16.5x24x1.8x
Wed, 23 Aug 2023US$772.8bUS$412.0bUS$31.2b15.2x24.8x1.9x
Fri, 21 Jul 2023US$828.7bUS$444.3bUS$39.1b14.2x21.2x1.9x
Sun, 18 Jun 2023US$801.5bUS$444.6bUS$39.1b12.9x20.5x1.8x
Tue, 16 May 2023US$777.2bUS$444.6bUS$39.2b12.8x19.8x1.7x
Thu, 13 Apr 2023US$804.1bUS$452.1bUS$42.6b12.9x18.9x1.8x
Sat, 11 Mar 2023US$778.8bUS$452.1bUS$42.6b12.3x18.3x1.7x
Price to Earnings Ratio

18.3x


Total Market Cap: US$778.8bTotal Earnings: US$42.6bTotal Revenue: US$452.1bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Chemicals Industry Price to Earnings3Y Average 42.2x202420252026
Current Industry PE
  • Investors are optimistic on the American Chemicals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 116x which is higher than its 3-year average PE of 42.1x.
  • The industry is trading close to its 3-year average PS ratio of 2.4x.
Past Earnings Growth
  • The earnings for companies in the Chemicals industry have declined 45% per year over the last three years,
  • Revenues have also declined 7.6% per year.
  • This means overall sales from these companies are declining and profits are subsequently falling as well.

Industry Trends

Which industries have driven the changes within the U.S. Materials industry?

US Market-0.57%
Materials2.63%
Chemicals1.03%
Diversified Chemicals4.25%
Commodity Chemicals2.41%
Fertilizers and Agricultural Chemicals1.91%
Industrial Gases1.41%
Specialty Chemicals0.27%
Industry PE
  • Investors are most optimistic about the Fertilizers and Agricultural Chemicals industry which is trading above its 3-year average PE ratio of 18.9x.
    • Analysts are expecting annual earnings growth of 13.9%, which is lower than the prior year's growth of 40.2% per year.
Forecasted Growth
  • Analysts are most optimistic on the Commodity Chemicals industry, expecting annual earnings growth of 68% over the next 5 years.
  • This is better than its past earnings decline of 22% per year.
  • In contrast, the Industrial Gases industry is expected to see its earnings grow by 14% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CF CF Industries HoldingsUS$106.3010.6%
+US$1.3b		41.2%PE11.2x
CTVA CortevaUS$78.931.2%
+US$645.6m		32.0%PE44.5x
RYAM Rayonier Advanced MaterialsUS$9.3730.7%
+US$147.4m		25.3%PS0.4x
LXU LSB IndustriesUS$11.9418.7%
+US$134.1m		77.9%PE34.9x
NEU NewMarketUS$631.751.9%
+US$112.4m		14.2%PE14.2x

Latest News

CF
US$106.30
CF Industries Holdings
7D
10.6%
1Y
41.2%
DD
US$48.27
DuPont de Nemours
7D
-5.5%
1Y
-37.9%
LXU
US$11.94
LSB Industries
7D
18.7%
1Y
77.9%
ALB
US$164.73
Albemarle
7D
-11.8%
1Y
128.3%
SHW
US$348.83
Sherwin-Williams
7D
-4.4%
1Y
-1.8%
NEU
US$631.75
NewMarket
7D
1.9%
1Y
14.2%
SQM
US$68.80
Sociedad Química y Minera de Chile
7D
-10.3%
1Y
79.3%
SXT
US$97.53
Sensient Technologies
7D
2.4%
1Y
41.9%

SXT: Future Natural Color Investments And Acquisitions Will Support Upside Potential

Analysts have nudged their price target on Sensient Technologies slightly higher to $119, pointing to relatively steady assumptions around fair value, discount rate, revenue growth, profit margin, and future P/E. What's in the News Sensient completed its long running share repurchase program announced in August 2014, having repurchased 6,267,019 shares, or 13.94% of the company, for a total of $440.29 million, with no shares repurchased in the most recent reported tranche (Key Developments).
LIN
US$501.68
Linde
7D
-0.5%
1Y
8.7%
BCPC
US$181.38
Balchem
7D
1.6%
1Y
6.3%

Encapsulation Investments And International Expansion Will Shape Balanced Future For Nutrition Specialist

Catalysts About Balchem Balchem produces specialty nutrition and ingredient solutions for human, animal and plant health, along with performance gases. What are the underlying business or industry changes driving this perspective?
RYAM
US$9.37
Rayonier Advanced Materials
7D
30.7%
1Y
25.3%
CTVA
US$78.93
Corteva
7D
1.2%
1Y
32.0%

CTVA: Sector Uncertainty And New Ventures Will Shape Forward Risk Balance

Corteva's analyst fair value estimate has edged up to $82.76 from $82.05 as analysts refine their models and price targets following recent earnings updates and a broad wave of upward target revisions across the Street. Analyst Commentary Recent Street research around Corteva reflects an active debate, with several firms adjusting price targets and a mix of upgrades and downgrades around the latest earnings update.
PPG
US$118.18
PPG Industries
7D
-5.9%
1Y
8.1%

PPG: Recent Rating Shifts And Macro Signals Will Shape Fairly Valued Outlook

Analysts have nudged their fair value estimate for PPG Industries higher from $123.75 to $125.30, citing a broad wave of recent price target increases across the Street as they update their assumptions while keeping core growth and margin views largely unchanged. Analyst Commentary The recent wave of price target adjustments for PPG Industries shows a mix of optimism and caution, with most research updates clustered over a short window and one earlier move taking a more guarded stance.
ECL
US$298.46
Ecolab
7D
-3.1%
1Y
11.5%

ECL: Fair Outlook As Sector Catalysts Meet Elevated Execution Risk

The analyst fair value estimate for Ecolab has shifted from about $296 to around $322 as analysts collectively raise price targets. This change reflects updated views on margin potential, valuation multiples, and the broader chemicals sector backdrop.
APD
US$273.04
Air Products and Chemicals
7D
-2.3%
1Y
-10.6%

APD: Backlog Execution And NASA Hydrogen Wins Will Shape Turnaround Path

The analyst price target for Air Products and Chemicals has been raised by about $1 to approximately $302, as analysts incorporate higher published targets from multiple firms and modest adjustments to assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E. Analyst Commentary Recent Street research on Air Products and Chemicals has centered on a series of upward price target revisions and one key rating change, providing a view into how analysts are framing valuation, execution risk, and growth potential.
HWKN
US$150.95
Hawkins
7D
2.9%
1Y
45.4%